MELISSA GABEL-ALVARADO: Open Payments
NPI 1174856025 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 7 payments from 5 companies in 2025. Trend: 2023 $17 · 2024 $674 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
Products named: AUSTEDO XR, ZORYVE, REXULTI, QULIPTA, DUPIXENT.
Industry payments across TX — which companies pay providers there.
